logo

Meridian Bioscience Inc. (VIVO)



Trade VIVO now with
  Date
  Headline
9/14/2020 10:08:15 AM Meridian Launches SARS-CoV-2 Antibody Pair Designed For Developing Sensitive Rapid Antigen Tests From Saliva Samples
7/28/2020 9:11:06 AM Meridian Bioscience Appoints Anthony Bihl To Its Board
5/26/2020 8:15:26 AM Meridian Bioscience To Supply Reagents For Manufacturing Of Tens Of Millions Of COVID-19 Antibody Tests Per Month
5/8/2020 7:35:28 AM Meridian Bioscience Q2 EPS $0.22 Vs $0.17 Last Year
4/2/2020 7:42:46 AM Meridian Bioscience Expects Q2 Revenues To Be $57 Mln Vs $50.2 Mln Last Year
3/16/2020 8:08:38 AM Meridian Bioscience Reports FDA-Clearance For New Curian Analyzer And Curian HpSA Assay
2/7/2020 7:36:10 AM Meridian Bioscience Q1 EPS On Reported GAAP Basis $0.07 And Adjusted EPS $0.10
1/27/2020 9:29:32 AM Meridian Bioscience: Lyo-Ready 1-Step RT-qPCR Mix Used In Development Of Diagnostics For New Coronavirus Outbreak
7/30/2019 7:38:34 AM Meridian Bioscience Q3 GAAP EPS $0.12, Adjusted EPS $0.16
4/30/2019 8:40:11 AM Meridian Bioscience Q2 EPS $0.17, Adj. EPS $0.19; Suspends Quarterly Dividend
2/7/2019 7:34:06 AM Meridian Launches New Range Of Lyo-Ready PCR Mixes
1/24/2019 7:33:15 AM Meridian Bioscience Q1 Net Earnings $8.1 Mln Or $0.19/shr Vs. $6.3 Mln Or $0.15/shr Last Year
12/6/2018 7:32:13 AM Meridian Gets FDA Clearance For New Neonatal Saliva CMV Test